Maxcyte (MXCT) Capital Expenditures (2020 - 2026)
Maxcyte (MXCT) reported Capital Expenditures of $24000.0 for Q1 2026, down 96.32% year-over-year from $653000.0 in Q1 2025, and up 101.6% on a QoQ basis from -$1.5 million in Q4 2025.
Maxcyte (MXCT) has 7 years of Capital Expenditures data on file, last reported at $24000.0 in Q1 2026.
- Quarterly Capital Expenditures fell 96.32% year-over-year to $24000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$596000.0 (down 126.05% YoY) and the FY2025 annual result came in at $33000.0, down 98.0% from the prior year.
- Capital Expenditures improved to $24000.0 in Q1 2026 per MXCT's latest filing, from -$1.5 million in the prior quarter.
- Across five years, Capital Expenditures topped out at $15.2 million in Q3 2022 and bottomed at -$15.9 million in Q4 2022.
- The 5-year median for Capital Expenditures is $147000.0 (2024), against an average of $339470.6.
- Peak annual rise in Capital Expenditures reached 28199.53% in 2022, while the deepest fall reached 1518.67% in 2022.
- Tracing MXCT's Capital Expenditures over 5 years: stood at -$15.9 million in 2022, then surged by 121.44% to $3.4 million in 2023, then tumbled by 95.69% to $147000.0 in 2024, then tumbled by 1123.13% to -$1.5 million in 2025, then soared by 101.6% to $24000.0 in 2026.
- Per Business Quant, the three latest MXCT Capital Expenditures figures stand at $24000.0 (Q1 2026), -$1.5 million (Q4 2025), and $300000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 399.00 Mn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 166.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 444.00 Mn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 177.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 64.90 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -85.46 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 76.60 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 86.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 90.20 Mn |
| 10 | Maxcyte | 129.85 Mn | 129.85 Mn | 8.08 Mn | 24,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 24,000.00 |
| Mar 31, 2026 | 24,000.00 |
| Dec 31, 2025 | -1.50 Mn |
| Dec 31, 2025 | -1.50 Mn |
| Sep 30, 2025 | 300,000.00 |
| Sep 30, 2025 | 300,000.00 |
| Jun 30, 2025 | 584,000.00 |
| Jun 30, 2025 | 584,000.00 |
| Mar 31, 2025 | 653,000.00 |
| Mar 31, 2025 | 653,000.00 |
| Dec 31, 2024 | 147,000.00 |
| Dec 31, 2024 | 147,000.00 |
| Sep 30, 2024 | 1.42 Mn |
| Sep 30, 2024 | 1.42 Mn |
| Jun 30, 2024 | 64,000.00 |
| Jun 30, 2024 | 64,000.00 |
| Mar 31, 2024 | 16,000.00 |
| Mar 31, 2024 | 16,000.00 |
| Dec 31, 2023 | 3.41 Mn |
| Dec 31, 2023 | 3.41 Mn |
| Sep 30, 2023 | -209,000.00 |
| Sep 30, 2023 | -209,000.00 |
| Jun 30, 2023 | -1.06 Mn |
| Jun 30, 2023 | -1.06 Mn |
| Mar 31, 2023 | 1.56 Mn |
| Mar 31, 2023 | 1.56 Mn |
| Dec 31, 2022 | -15.92 Mn |
| Dec 31, 2022 | -15.92 Mn |
| Sep 30, 2022 | 15.21 Mn |
| Sep 30, 2022 | 15.21 Mn |
| Jun 30, 2022 | -4.92 Mn |
| Jun 30, 2022 | -4.92 Mn |
| Mar 31, 2022 | 6.00 Mn |
| Mar 31, 2022 | 6.00 Mn |
| Dec 31, 2021 | 1.12 Mn |
| Dec 31, 2021 | 1.12 Mn |
| Sep 30, 2021 | 1.44 Mn |
| Sep 30, 2021 | 1.44 Mn |
| Jun 30, 2021 | 1.25 Mn |
| Jun 30, 2021 | 1.25 Mn |
| Mar 31, 2021 | 21,200.00 |
| Mar 31, 2021 | 21,200.00 |
| Dec 31, 2020 | -1.64 Mn |
| Dec 31, 2020 | -1.64 Mn |
| Sep 30, 2020 | 663,400.00 |
| Sep 30, 2020 | 663,400.00 |